Use of [D-MeAla]3-[EtVal]4-cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said [D-MeAla]3-[EtVal]4-cyclosporin

Details for Australian Patent Application No. 2005290984 (hide)

Owner Debiopharm SA

Inventors Scalfaro, Pietro; Vuagniaux, Gregoire; Mauvernay, Rolland-Yves; Dumont, Jean-Maurice

Agent Spruson & Ferguson

Pub. Number AU-B-2005290984

PCT Pub. Number WO2006/038088

Priority PCT/ IB2004/003205 01.10.04 IB

Filing date 3 October 2005

Wipo publication date 13 April 2006

Acceptance publication date 9 September 2010

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/038088 Priority application(s): WO2006/038088

9 September 2010 Application Accepted

  Published as AU-B-2005290984

13 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005290997-Novel cancer associated antibodies and antigens and their use in cancer diagnosis

2005290980-Use of pharmaceutical compositions of lofepramine for the treatment of ADHD, CFS, FM and depression